News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Recalls Weight-Loss Drug Alli In U.S. After Tampering



3/27/2014 8:54:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Some bottles of Alli, GlaxoSmithKline Plc's weight-loss drug sold over the counter in the United States, have been tampered with, and the Food and Drug Administration was investigating, the company said on Wednesday. Consumers have reported that about 20 bottles bought in stores in seven mostly Southern states contained products other than the drug, GlaxoSmithKline said. The company said the affected bottles from five lots of the drug could contain tablets and capsules of different shapes and colors.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Fox News
Read at Nasdaq
Read at NPR News
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES